The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial
The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial
Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Amal A. El-Kholy, Manal El‐Hamamsy et al.
Citations
9 citations
Journal
Diabetologia
Topics
Diabetes Treatment and Management
Field-Weighted Citation Impact (FWCI)
3.22
article
The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial
Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Amal A. El-Kholy, Manal El‐Hamamsy, Marwa Zaki Ibrahim
article en
9 citations
Abstract
No abstract available for this paper.
Publication Tag
DiabetologiaVol. 67(12)
Institutions
Ain Shams University (EG), Ahram Canadian University (EG)